The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

Invesco Pharmaceuticals ETF (PJP) delivers higher returns (32.8% over one year, 10.7% CAGR since 2021) with concentrated U.S. pharma exposure but higher fees (0.58%), while iShares Global Healthcare ETF (IXJ) offers broader global diversification across 109 holdings, lower costs (0.38%), and higher dividend yield (1.3%), making it suitable for cost-conscious investors seeking diversified healthcare exposure.